ExpreS2ion Biotech Holding AB (publ)
EXPRS2
Rank in Stocks
#33781
Based in Horsholm, Denmark, ExpreS2ion Biotech Holding AB, along with its... Based in Horsholm, Denmark, ExpreS2ion Biotech Holding AB, along with its subsidiary ExpreS2ion Biotechnologies, specializes in creating and manufacturing complex proteins for use in vaccines and diagnostic products. The company's development pipeline includes a capsid virus-like particle COVID-19 vaccine, an influenza vaccine, and a breast cancer vaccine, all of which are currently undergoing Phase II clinical trials. ExpreS2ion is also engaged in developing a malaria vaccine. Furthermore, the company extends its reach by licensing its proprietary ExpreS2 platform to various research organizations and pharmaceutical businesses. ExpreS2ion Biotech Holding AB commenced operations in 2015.
Share Price
$0.09325189
Last synced: 2026-11-09
Market Cap
$237.89K
Change (1 day)
-0.60%
Change (1 year)
-94.75%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade ExpreS2ion Biotech Holding AB (publ) (EXPRS2)
Category
Healthcare
Number of shares outstanding for ExpreS2ion Biotech Holding AB (publ) (EXPRS2)
Number of shares outstanding as of June 2026: 36.01M
According to ExpreS2ion Biotech Holding AB (publ)'s latest financial reports, its current number of shares outstanding is 36.01M. At the end of 2025 the company had 2.84M shares outstanding. The number of shares outstanding usually changes with stock splits and share buybacks.
Shares outstanding history for ExpreS2ion Biotech Holding AB (publ) (EXPRS2) from 2013 to 2026
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2026 (TTM) | 36.01M | 1,165.83% |
| 2025 | 2.84M | 68.23% |
| 2024 | 1.69M | 46.57% |
| 2023 | 1.15M | 22.28% |
| 2022 | 943.47K | 17.02% |
| 2021 | 806.21K | 68.61% |
| 2020 | 478.16K | 18.11% |
| 2019 | 404.84K | 9.99% |
| 2018 | 368.06K | 21.14% |
| 2017 | 303.82K | 7.00% |
| 2016 | 283.94K | 56.58% |
| 2015 | 181.34K | 0.00% |
| 2014 | 181.34K | 0.00% |
| 2013 | 181.34K | 0.00% |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | Difference | Country |
|---|---|---|---|
| 253.50M | 604.00% |
US
|
|
| 401.00M | 1,013.62% |
US
|
|
| 478.91M | 1,230.00% |
AU
|
|
| 0.00 | -100.00% |
BE
|
|
| 62.74M | 74.22% |
NL
|
Questions about ExpreS2ion Biotech Holding AB (publ)'s number of shares outstanding
What is ExpreS2ion Biotech Holding AB (publ)'s number of shares outstanding?
ExpreS2ion Biotech Holding AB (publ)'s number of shares outstanding is 36.01M, as of Jun 2026.
What was ExpreS2ion Biotech Holding AB (publ)'s number of shares outstanding in 2025?
In 2025, ExpreS2ion Biotech Holding AB (publ)'s number of shares outstanding was 2.84M, 68.23% more than in 2024 (1.69M).
How has ExpreS2ion Biotech Holding AB (publ)'s number of shares outstanding changed since 2020?
From 2020 to 2025, ExpreS2ion Biotech Holding AB (publ)'s number of shares outstanding went from 478.16K to 2.84M, an average growth of 42.85% a year.